Belej, M. A.; Smith, D. G.; Aviado, D. M.
view article (9.580606)
Toxicity of Aerosol Propellants on the Respiratory and Circulatory Systems. Part 4. Cardiotoxicity in the Monkey.
University of Pennsylvania School of Medicine, Philadlphia, PA
Toxicology,
Vol. 2,
No. 4,
381-395,
December 1974
Aviado, D. M.; Drimal, J.
view article (9.580606)
Five Fluorocarbons for Administration of Aerosol Bronchodilators.
Pennsylvania State Univ., University Park
Journal of Clinical Pharmacology,
Vol. 15,
No. 2,
116-128,
January 1975
Aviado, D. M.; Belej, M. A.
view article (9.30499)
Toxicity of Aerosol Propellants on the Respiratory and Circulatory Systems. Part 1. Cardiac Arrhythmia in the Mouse.
University of Pennsylvania School of Medicine, Philadlphia, PA
Toxicology,
Vol. 2,
No. 1,
31-42,
March 1974
Aviado, D. M.; Smith, D. G.
view article (9.30499)
Toxicity of Aerosol Propellants on the Respiratory and Circulatory Systems. Part 8. Respiration and Circulation in Primates.
University of Pennsylvania School of Medicine, Philadlphia, PA
Toxicology,
Vol. 3,
No. 2,
241-252,
1975
Simaan, J. A.; Aviado, D. M.
view article (9.30499)
Hemodynamic Effects of Aerosol Propellants. Part 1. Cardiac Depression in the Dog.
Pennsylvania State Univ., University Park
Toxicology,
Vol. 5,
No. 2,
127-138,
November 1975
Friedman, S. A.; Cammarato, M.; Aviado, D. M.
view article (9.300467)
Toxicity of Aerosol Propellants on the Respiratory and Circulatory Systems. Part 2. Respiratory and Bronchopulmonary Effects in the Rat.
University of Pennsylvania School of Medicine, Philadlphia, PA
Toxicology,
Vol. 1,
No. 4,
345-355,
1973
Aviado, D. M.; Belej, M. A.
view article (9.300467)
Toxicity of Aerosol Propellants on the Respiratory and Circulatory Systems. Part 5. Ventricular Function in the Dog.
University of Pennsylvania School of Medicine, Philadlphia, PA
Toxicology,
Vol. 3,
No. 1,
79-86,
January 1975
Belej, M. A.; Aviado, D. M.
view article (9.300467)
Cardiopulmonary Toxicity of Propellants for Aerosols.
Pennsylvania State Univ., University Park
Journal of Clinical Pharmacology,
Vol. 14,
No. 1,
105-115,
January 1975
Food and Drug Administration, Washington, DC,